Trial intelligence / Profile preview

EEG-derived pain threshold index-guided versus standard care during remifentanil–propofol anesthesia

ChiCTR2100045011Phase 4Recruiting

Sponsor
First Affiliated Hospital of Anhui Medical University
Start
Apr 2021
Modality
Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of remifentanil and propofol in None (2 arms), sponsored by First Affiliated Hospital of Anhui Medical University. Primary endpoint: Remedial analgesia rate. Started Apr 2021; status: recruiting.

02

Drugs

remifentanilpropofol

Beyond the preview

Go deeper on ChiCTR2100045011.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2100045011.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call